Sanofi Consumer Healthcare India Limited — Updates, 02-05-2025: Press Release

Sanofi Consumer Healthcare India Ltd reported a 12.9% rise in PAT to ₹50 Cr and revenue of ₹172.6 Cr in Q1, with EPS up to ₹21.7. Growth was driven by the launch of Allegra D, strengthening its allergy portfolio. After the demerger from Sanofi India Ltd, SCHIL is fully focused on consumer healthcare, leveraging key brands like Allegra, DePURA, Avil, and Combiflam to fuel expansion in allergy, digestive wellness, pain care, and supplements. Management highlights commitment to high-quality, science-backed products.